Key facts
- It has raised $388.5M; the latest was Later Stage VC ($310.0M) in Aug 2024.
- Notable investors include Plug and Play Tech Center, Intel Capital, BlackRock, Arkin Capital, Optum Ventures — 38 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for Caresyntax
- ·The full record, as it builds
Funding rounds
No funding rounds for Caresyntax are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Caresyntax
Developer of a data-driven surgical analysis platform designed to improve patient outcomes. The company's platform utilizes artificial intelligence to analyze large volumes of video, audio, images, and clinical and operational data in and around the operating room, enabling healthcare businesses to gain insights that can be used live during surgery, for post-surgical improvement, and risk assessment.
- Sector
- Healthcare
- HQ
- Larkspur, CA, United States
- Founded
- 2013
- Employees
- 150
- Website
- caresyntax.com/
- Ownership
- Privately Held (backing)
Caresyntax doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Caresyntax shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Caresyntax in its N-PORT filings yet. We sweep new filings monthly.